Scalper1 News
Five notable IBD 50 stocks are all set to issue their quarterly earnings in the coming week. United Therapeutics (UTHR) reports before the open on Tuesday. The cancer therapy developer’s stock is up 20% so far this year. Valeant Pharmaceuticals (VRX) also reports before the open on Tuesday. It could close its $160-a-share buyout deal with industry group peer Salix Pharmaceuticals (SLXP) soon. Valeant shares are up 21% in 2015. Apple (AAPL) chip Scalper1 News
Scalper1 News